Fingerprint
Dive into the research topics of 'Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically